Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 1 | 0 | €22.15 | €55.13 | 148.912% |
| Alkermes plc | 17 | 2 | 0 | 0 | €25.20 | €35.01 | 38.941% |
| Chromadex Corp | 10 | 1 | 0 | 0 | €3.00 | €5.55 | 85.120% |
| Evolus Inc | 11 | 0 | 2 | 0 | €14.10 | €22.65 | 60.665% |
| Brainstorm Cell | 2 | 0 | 0 | 0 | €0.28 | €1.84 | 557.245% |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €224.50 | €315.00 | 40.312% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €2.68 | €3.00 | 12.024% |
| Krystal Biotech | 20 | 0 | 4 | 0 | €176.45 | €185.58 | 5.174% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.84 | - | - |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €330.50 | €418.12 | 26.512% |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | €12.50 | €20.33 | 62.668% |
| Arca Biopharma | 2 | 17 | 2 | 0 | €2.28 | €7.50 | 228.947% |
| Personalis Inc | 10 | 1 | 3 | 0 | €5.24 | €6.58 | 25.723% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | €10.28 | €26.24 | 155.214% |
| Actinium Pharmaceuticals Inc. | 1 | 2 | 1 | 2 | €1.74 | €1.00 | -42.463% |
| United Therapeutics | 27 | 1 | 5 | 1 | €325.20 | €341.51 | 5.015% |
| Incyte Corp. | 13 | 2 | 1 | 0 | €59.54 | €77.67 | 30.452% |
| Polynovo Ltd | 1 | 0 | 0 | 0 | €1.45 | - | - |
| XOMA Corp. | 9 | 0 | 1 | 0 | €25.40 | €68.62 | 170.158% |
| Precision BioSciences Inc | 9 | 0 | 1 | 0 | €0.35 | €17.75 | 5001.609% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €5.18 | €16.55 | 219.826% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | €1,064.5 | €1,091.9 | 2.573% |
| Exact Sciences | 17 | 0 | 2 | 0 | €55.04 | €75.89 | 37.883% |
| G1 Therapeutics | 19 | 1 | 0 | 0 | €6.41 | €11.09 | 73.133% |